| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Departments of Medicine and Surgery [K. S., A. J. D.], Joan and Sanford I. Weill Medical College of Cornell University and Anne Fisher Nutrition Center [K. S., J. R. M., A. J. D.] at Strang Cancer Prevention Center, New York, New York 10021; Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [P. M., J. R. M., P. G. S.]; Institute of Cancer Research, College of Physicians & Surgeons of Columbia University, New York, New York 10032 [A. M. C., D. G.]; Searle Discovery Research, Monsanto Co., St. Louis, Missouri 63167 [J. L. M., B. S. Z., C. K.]; and the Department of Pharmacology, National Cardiovascular Center Research Institute, Osaka 565, Japan [T. T.]
We investigated the mechanisms by which caffeic acid phenethyl ester (CAPE), a phenolic antioxidant, inhibited the stimulation of prostaglandin (PG) synthesis in cultured human oral epithelial cells and in an animal model of acute inflammation. Treatment of cells with CAPE (2.5 µg/ml) suppressed phorbol ester (12-O-tetradecanoylphorbol-13-acetate; TPA) and calcium ionophore (A23187)-mediated induction of PGE2 synthesis. This relatively low concentration of CAPE did not affect amounts of cyclooxygenase (COX) enzymes. CAPE nonselectively inhibited the activities of baculovirus-expressed hCOX-1 and hCOX-2 enzymes. TPA- and A23187-stimulated release of arachidonic acid from membrane phospholipids was also suppressed by CAPE (48 µg/ml). Higher concentrations of CAPE (1020 µg/ml) suppressed the induction of COX-2 mRNA and protein mediated by TPA. Transient transfections using human COX-2 promoter deletion constructs were performed; the effects of TPA and CAPE were localized to a 124-bp region of the COX-2 promoter. In the rat carrageenan air pouch model of inflammation, CAPE (10100 mg/kg) caused dose-dependent suppression of PG synthesis. Amounts of COX-2 in the pouch were markedly suppressed by 100 mg/kg CAPE but were unaffected by indomethacin. These data are important for understanding the anticancer and anti-inflammatory properties of CAPE.
This article has been cited by other articles:
![]() |
H. Yilmaz, E Uz, O Gokalp, N Ozcelik, E Cicek, and M. Ozer Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats Toxicology and Industrial Health, September 1, 2008; 24(8): 519 - 524. [Abstract] [PDF] |
||||
![]() |
O. Beltran-Ramirez, L. Aleman-Lazarini, M. Salcido-Neyoy, S. Hernandez-Garcia, S. Fattel-Fazenda, E. Arce-Popoca, J. Arellanes-Robledo, R. Garcia-Roman, P. Vazquez-Vazquez, A. Sierra-Santoyo, et al. Evidence that the Anticarcinogenic Effect of Caffeic Acid Phenethyl Ester in the Resistant Hepatocyte Model Involves Modifications of Cytochrome P450 Toxicol. Sci., July 1, 2008; 104(1): 100 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Jung, H. S. Kim, C. S. Lee, D.-H. Park, Y.-N. Kim, M.-J. Lee, J. W. Lee, J.-W. Park, M.-S. Kim, S. K. Ye, et al. Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells Carcinogenesis, August 1, 2007; 28(8): 1780 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guney, S. Nasir, B. Oral, N. Karahan, and T. Mungan Effect of Caffeic Acid Phenethyl Ester on the Regression of Endometrial Explants in an Experimental Rat Model Reproductive Sciences, April 1, 2007; 14(3): 270 - 279. [Abstract] [PDF] |
||||
![]() |
F. Oktem, H R. Yilmaz, F. Ozguner, S. Olgar, A. Ayata, E. Uzar, and E. Uz Methotrexate-induced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester Toxicology and Industrial Health, July 1, 2006; 22(6): 241 - 247. [Abstract] [PDF] |
||||
![]() |
F. Ozguner, A. Altinbas, M. Ozaydin, A. Dogan, H. Vural, A N. Kisioglu, G. Cesur, and N. G. Yildirim Mobile phone-induced myocardial oxidative stress: protection by a novel antioxidant agent caffeic acid phenethyl ester Toxicology and Industrial Health, August 1, 2005; 21(7-8): 223 - 230. [Abstract] [PDF] |
||||
![]() |
D.-B. Shieh, S.-R. Yang, X.-Y. Shi, Y.-N. Wu, and S.-N. Wu Properties of BKCa Channels in Oral Keratinocytes Journal of Dental Research, May 1, 2005; 84(5): 468 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-W. CHUNG, S.-K. MOON, Y.-C. CHANG, J.-H. KO, Y.-C. LEE, G. CHO, S.-H. KIM, J.-G. KIM, and C.-H. KIM Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism FASEB J, November 1, 2004; 18(14): 1670 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Marquez, R. Sancho, A. Macho, M. A. Calzado, B. L. Fiebich, and E. Munoz Caffeic Acid Phenethyl Ester Inhibits T-Cell Activation by Targeting Both Nuclear Factor of Activated T-Cells and NF-{kappa}B Transcription Factors J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 993 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. LEVINE Does the release of arachidonic acid from cells play a role in cancer chemoprevention? FASEB J, May 1, 2003; 17(8): 800 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Scapagnini, R. Foresti, V. Calabrese, A. M. G. Stella, C. J. Green, and R. Motterlini Caffeic Acid Phenethyl Ester and Curcumin: A Novel Class of Heme Oxygenase-1 Inducers Mol. Pharmacol., March 1, 2002; 61(3): 554 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Fitzpatrick, J. Wang, and T. Le Caffeic Acid Phenethyl Ester, an Inhibitor of Nuclear Factor-kappa B, Attenuates Bacterial Peptidoglycan Polysaccharide-Induced Colitis in Rats J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 915 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Subbaramaiah, P. Bulic, Y. Lin, A. J. Dannenberg, and D. S. Pasco Development and Use of a Gene Promoter-Based Screen to Identify Novel Inhibitors of Cyclooxygenase-2 Transcription J Biomol Screen, April 1, 2001; 6(2): 101 - 110. [Abstract] [PDF] |
||||
![]() |
M. B. Sporn and N. Suh Chemoprevention of cancer Carcinogenesis, March 1, 2000; 21(3): 525 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Weyant, A. M. Carothers, M. E. Bertagnolli, and M. M. Bertagnolli Colon Cancer Chemopreventive Drugs Modulate Integrin-mediated Signaling Pathways Clin. Cancer Res., March 1, 2000; 6(3): 949 - 956. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |